Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
RESEARCH TOOLSreports
NewAmsterdam Pharma Company (NAMS) Stock Price & Analysis
57 Followers
NAMS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.63 - $26.35
Previous Close$19.74
Volume36.50K
Average Volume (3M)229.76K
Market Cap
$1.74B
Enterprise Value$1.32B
Total Cash (Recent Filing)$438.52M
Total Debt (Recent Filing)$118.00K
Price to Earnings (P/E)N/A
Beta0.64
Next Earnings
May 06, 2024EPS Estimate
-$0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding89,266,673
10 Day Avg. Volume198,492
30 Day Avg. Volume229,756
Standard Deviation0.24
R-Squared0.00038
Alpha0.09
Financial Highlights & Ratios
Price to Book (P/B)-8.68
Price to Sales (P/S)18.04
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit35.87
Enterprise Value/Ebitda-566.81
Forecast
1Y Price Target
$33.60Price Target Upside72.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
NewAmsterdam Pharma Company News
Ownership Overview
7.66% Insiders
0.05% Mutual Funds
3.24% Other Institutional Investors
89.05% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NAMS FAQ
What was NewAmsterdam Pharma Company’s price range in the past 12 months?
NewAmsterdam Pharma Company lowest stock price was $5.63 and its highest was $26.35 in the past 12 months.
What is NewAmsterdam Pharma Company’s market cap?
Currently, no data Available
When is NewAmsterdam Pharma Company’s upcoming earnings report date?
NewAmsterdam Pharma Company’s upcoming earnings report date is May 06, 2024 which is in 7 days.
How were NewAmsterdam Pharma Company’s earnings last quarter?
NewAmsterdam Pharma Company released its earnings results on Feb 28, 2024. The company reported -$0.6 earnings per share for the quarter, beating the consensus estimate of -$0.605 by $0.005.
Is NewAmsterdam Pharma Company overvalued?
According to Wall Street analysts NewAmsterdam Pharma Company’s price is currently Undervalued.
Does NewAmsterdam Pharma Company pay dividends?
NewAmsterdam Pharma Company does not currently pay dividends.
What is NewAmsterdam Pharma Company’s EPS estimate?
NewAmsterdam Pharma Company’s EPS estimate is -$0.55.
How many shares outstanding does NewAmsterdam Pharma Company have?
NewAmsterdam Pharma Company has 89,266,670 shares outstanding.
What happened to NewAmsterdam Pharma Company’s price movement after its last earnings report?
NewAmsterdam Pharma Company reported an EPS of -$0.6 in its last earnings report, beating expectations of -$0.605. Following the earnings report the stock price went down -2.518%.
Which hedge fund is a major shareholder of NewAmsterdam Pharma Company?
Among the largest hedge funds holding NewAmsterdam Pharma Company’s share is Viking Global Investors LP. It holds NewAmsterdam Pharma Company’s shares valued at 90M.
---
NewAmsterdam Pharma Company Stock Smart Score
Company Description
NewAmsterdam Pharma Company
Frazier Lifesciences Acquisition Corp is a blank check company.
---
NAMS Stock 12 Months Forecast
Average Price Target
$33.60
▲(72.31% Upside)
Technical Analysis
Assembly Biosciences
―
Eiger Biopharmaceuticals
―
Sangamo Biosciences
―
Gilead Sciences
―
Best Analysts Covering NAMS
1 Year
1 Year Success Rate
6/8 ratings generated profit
1 Year Average Return
+52.49%
reiterated a buy rating 2 months ago
Copying Roanna Ruiz's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +52.49% per trade.
---